通用金融 GNW 深 沪
等待开盘 08-06 09:30:00 美东时间
7.96
+0.100
+1.27%
华盛通- 最 高7.99
- 今 开7.87
- 成交量 494.05万股
- 最 低 7.84
- 昨 收 7.86
- 总市值 32.95亿
- 52周最高 8.285
- 市盈率 静 11.70
- 换手率 0.00%
- 52周最低 5.99
- 委 比 -12.74%
- 总股本 4.14亿
- 历史最高 18.74
- 量 比 0.64
- 振 幅 1.91%
- 历史最低 1.57
- 每 手 1
- 风险率 0.41%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多大厂不再重压ChatBot、“六小虎”声量分化、机器人不依赖绳索“吊着”｜WAIC观察
“自拍杆都拍不到”“机器人不是被吊着了”“谁家来了谁家没来”“卖票卖票”……在上海天气反复无常的情况下，WAIC连续四天场内外都在上演人海大战，据官方披露约3...
07-30 21:37
蚂蚁数科发布金融推理大模型，金融智能体“长跑”提速 | 最前线
作者 | 王方玉 编辑 | 苏建勋 AI大模型作为新一代人工智能的基石，为金融行业的智能化提供了强大的技术底座，降低了开发和应用的门槛，堪称金融智能化的“新基建...
07-29 17:25
Genworth Financia Issues Statement In Response To A UK High Court Judgment In Favor Of AXA In The Legal Proceedings Against Santander; The Judgment Finds Santander Liable For AXA's Losses Resulting From Santander's Mis-selling; Genworth Is Entitled To Share In Funds That AXA Recovers From Third Parties Related To The Mis-Selling Losses; Genworth Would Expect At That Time To Recover ~ $750M
Genworth Financial, Inc. (NYSE:GNW) today issued a statement in response to a UK High Court judgment in favor of AXA in the legal proceedings against Santander companies related to liabilities associated with the
07-25 21:42
美股大行评级 | 潜在涨幅107.37%！花旗上调ProKidney目标价至9美元，维持"买入"评级
今日重点评级关注：花旗：维持ProKidney Corp. - Class A Ordinary Shares"买入"评级，目标价从6美元升至9美元；Canaccord Genuity：维持e.l.f. Beauty"买入"评级，目标价从114美元升至150美元
07-10 09:55
Keefe, Bruyette & Woods Maintains Outperform on Genworth Financial, Raises Price Target to $9.5
Keefe, Bruyette & Woods analyst Ryan Krueger maintains Genworth Financial (NYSE:GNW) with a Outperform and raises the price target from $9 to $9.5.
07-10 01:00
美股大行评级 | 潜在涨幅261.01%！瑞穗上调Immuneering目标价至10美元，维持"跑赢大市"评级
康托·菲茨杰拉德：维持Meta Platforms(META)"超配"评级，目标价从676美元升至807美元
06-19 09:23
Keefe, Bruyette & Woods Upgrades Genworth Financial to Outperform, Raises Price Target to $9
Keefe, Bruyette & Woods analyst Ryan Krueger upgrades Genworth Financial (NYSE:GNW) from Market Perform to Outperform and raises the price target from $8.5 to $9.
06-18 23:14
美股大行评级 | 潜在涨幅158.9%！蒙特利尔银行上调Disc Medicine目标价至120美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1129333511617925121.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 蒙特利尔银行：维持Disc Medicine(IRON)"跑赢大市"评级，目标价从112美元升至120美元</p> <p>• 巴克莱：维持Karyopharm Therapeutics(KPTI)"超配"评级，目标价从5美
05-14 08:48
Keefe, Bruyette & Woods Maintains Market Perform on Genworth Financial, Raises Price Target to $8.5
Keefe, Bruyette & Woods analyst Ryan Krueger maintains Genworth Financial (NYSE:GNW) with a Market Perform and raises the price target from $8 to $8.5.
05-14 01:25
